Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017636 (
glioblastoma
)
18,345
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Transmembrane protein 39A
(
TMEM39A
) belongs to the TMEM39 family.
TMEM39A
gene is a susceptibility locus for multiple sclerosis. In addition,
TMEM39A
seems to be implicated in systemic lupus erythematosus. However, any possible involvement of
TMEM39A
in cancer remains largely unknown. In the present report, we provide evidence that
TMEM39A
may play a role in brain tumors. Western blotting using an anti-
TMEM39A
antibody indicated that
TMEM39A
was overexpressed in
glioblastoma
cell lines, including U87-MG and U251-MG. Deep-sequencing transcriptomic profiling of U87-MG and U251-MG cells revealed that
TMEM39A
transcripts were upregulated in such cells compared with those of the cerebral cortex. Confocal microscopic analysis of U251-MG cells stained with anti-
TMEM39A
antibody showed that
TMEM39A
was located in dot-like structures lying close to the nucleus.
TMEM39A
probably located to mitochondria or to endosomes. Immunohistochemical analysis of glioma tissue specimens indicated that
TMEM39A
was markedly upregulated in such samples. Bioinformatic analysis of the Rembrandt knowledge base also supported upregulation of
TMEM39A
mRNA levels in glioma patients. Together, the results afford strong evidence that
TMEM39A
is upregulated in glioma cell lines and glioma tissue specimens. Therefore,
TMEM39A
may serve as a novel diagnostic marker of, and a therapeutic target for, gliomas and other cancers.
...
PMID:Recognition of Transmembrane Protein 39A as a Tumor-Specific Marker in Brain Tumor. 2813 15